DGX vs TMP · P/E 22, rev $9.87B vs P/E 7.5, rev $79.3M
Quest Diagnostics Incorporated (DGX) versus Tompkins Financial Corporation (TMP) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Tompkins Financial Corporation (TMP) is a banks - regional company listed on AMEX.
Latest reported DGX revenue for 2024-12-31 was $9.87B. Net income was $921.0M. Revenue was up 6.7% from 2023-12-31 to 2024-12-31. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported TMP revenue for 2024-12-31 was $79.3M. Net income was $71.0M. Revenue was up 5.7% from 2023-12-31 to 2024-12-31. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
Not investment advice. Open the DGX and TMP stock pages for the full models.
Not investment advice.